FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/04/2026
Voltar para busca
Dado oficial do USPTO
PHARMAGUARD
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PHARMAGUARD
ST13
US500000079391761Classe
10, 16
Pedido
79391761
Registro
7756930
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
17/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
10, 16
Data de depósito
13/12/2023
Data de registro
15/04/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/04/2025
Última transação
17/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
09
Localização do titular
CH
Examinador
MANCA, ALBERTO I
Unidade examinadora
L80
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
SÜDPACK Medica AG
Südpack Verpackungen SE & Co. KG
Südpack Verpackungen GmbH & Co. KG
Representantes
Shoko Naruo Thompson Coburn LLP
Classificação técnica
Classes Nice
Classe 10Classe 16
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 10
Containers for medical purposes and for diagnostic purposescontainers for medical wastecontainers specially designed for transporting and holding liquid pharmaceuticals; flexible plastic bags and blister packs for medical and pharmaceutical liquidsbags for medical wasteblood collection bags for medical purposesbody fluids collection bags for medical purposesintravenous bags sold empty for intravenous therapyplastic blister packs for transmitting liquid medical specimens; flexible plastic bags and blister packs for biological liquidsfor medical purposesbags for medical wasteblood collection bags for medical purposesbody fluids collection bags for medical purposesintravenous bags sold empty for intravenous therapyplastic blister packs for transmitting liquid medical specimens; cell culture bags for medical purposesfor cell cultivation; permeable plastic films for medical purposes; drug delivery devices sold emptybags for use in drug delivery and receptacles for applying medicines; sterile pouchesfor medical usesfor the collection and disposal of emesis wastetransmitting medical specimens; pouchessheaths and containersfor collection of human medical waste in the nature of excretions for medical purposes; bags and case being containers for medical wastecontainers especially made for medical waste
Classe 16
Plastic material in the nature of pouchesbagsblister packs for packaging; materials for packagingfoils of plastic; printed and unprinted plastic foils for packaging; plastic materials for packagingfoils and foil bags; plastic materials for packagingvacuum packaging and protective gas filled packaging in the nature of plastic foilsbeing industrial packaging; plastic materials for packagingfoilspouchesenvelopesblister packs; tubular bags for packaging being cardboard tubes for packaging; papercardboard and products made from these materialspackages being packaging containers of paper and cardboard and wrapping materials in the nature of wrapping paper; biodegradable packagingof plastic materialsbiodegradable plastic pouchesbagsblister packs for packaging
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/03/2026
FIMP
FINAL DISPOSITION PROCESSED
25/03/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/09/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/08/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
20/08/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
15/07/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
15/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
15/04/2025
CHLD
CHANGE OF OWNER RECEIVED FROM IB
07/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/02/2025
PUBO
PUBLISHED FOR OPPOSITION
25/02/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/02/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
04/02/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/02/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
04/02/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/02/2025
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/02/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
14/01/2025
ISCR
WITHDRAWN FROM ISSUE - OG REVIEW QUERY
10/01/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/01/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
27/12/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/12/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
27/12/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/12/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/08/2024
RFNT
REFUSAL PROCESSED BY IB
28/07/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
27/06/2024
RFRR
REFUSAL PROCESSED BY MPU
27/06/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/06/2024
CNRT
NON-FINAL ACTION WRITTEN
29/05/2024
DOCK
ASSIGNED TO EXAMINER
23/05/2024
MAFR
APPLICATION FILING RECEIPT MAILED
26/03/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
22/03/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
21/03/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PHARMAGUARD ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.